These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 993321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G.
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [Abstract] [Full Text] [Related]

  • 5. Bartter's syndrome. New insights into pathogenesis and treatment.
    Solomon RJ, Brown RS.
    Am J Med; 1975 Oct; 59(4):575-83. PubMed ID: 1166859
    [Abstract] [Full Text] [Related]

  • 6. [Hypokalemic alkalosis with hyperplasia of the juxtaglomerular apparatus: Bartter's syndrome?].
    Codaccioni JL, Boyer J, Jubelin J, Conte-Devolx B, Hebreard J.
    Ann Endocrinol (Paris); 1972 Oct; 33(3):281-4. PubMed ID: 4346620
    [No Abstract] [Full Text] [Related]

  • 7. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
    Tamura Y, Matsuda Y, Yamada K, Takagi T, Nishikawa T, Watanabe M, Mikami K, Moriya H, Kumagai A.
    Adv Exp Med Biol; 1979 Oct; 120B():515-24. PubMed ID: 517245
    [No Abstract] [Full Text] [Related]

  • 8. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.
    Shimamoto K, Ura N, Tanaka S, Ogasawara A, Nakao T, Nakahashi Y, Chao J, Margolius HS, Iimura O.
    Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609
    [Abstract] [Full Text] [Related]

  • 9. Bartter's syndrome.
    Bartter FC.
    Urol Clin North Am; 1977 Jun; 4(2):253-61. PubMed ID: 331616
    [Abstract] [Full Text] [Related]

  • 10. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM, Gill JR, Bowden RE, Pisano JJ, Izzo JL, Radfar N, Taylor AA, Zusman RM, Bartter FC, Keiser HR.
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [Abstract] [Full Text] [Related]

  • 11. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H, Kawasaki T, Okumura M, Asano T, Abe K, Arakawa K.
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract] [Full Text] [Related]

  • 12. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L, Mark AL, Kaloyanides GJ.
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [Abstract] [Full Text] [Related]

  • 13. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH, Hewitt GJ, Mitchell MD.
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [Abstract] [Full Text] [Related]

  • 14. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M, Abe K, Yasujima M, Otsuka Y, Chiba S, Haruyama T, Yoshinaga K, Saito T, Kabuki J.
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [Abstract] [Full Text] [Related]

  • 15. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R.
    Dtsch Med Wochenschr; 1975 Nov 21; 100(47):2443-8. PubMed ID: 171132
    [Abstract] [Full Text] [Related]

  • 16. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and normal juxtaglomerular apparatus--a new syndrome of renal alkalosis.
    Barakat AY, Francis YK, Mufarrij AA.
    Int J Pediatr Nephrol; 1986 Nov 21; 7(2):99-100. PubMed ID: 3522459
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA, Lopez-Moreno JM, Mahana D.
    Hypertension; 1985 Nov 21; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [Abstract] [Full Text] [Related]

  • 18. Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
    Seino M, Abe K, Sakurai Y, Irokawa N, Yasujima M, Chiba S, Otsuka Y, Yoshinaga K.
    Tohoku J Exp Med; 1977 Feb 21; 121(2):111-9. PubMed ID: 847738
    [Abstract] [Full Text] [Related]

  • 19. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K, Schreiber V, Dvoráková J.
    Exp Clin Endocrinol; 1984 Jul 21; 84(1):105-11. PubMed ID: 6090182
    [Abstract] [Full Text] [Related]

  • 20. Bartter's syndrome--case report.
    Miyoshi A, Makino H, Hiramatsu M, Takahashi K, Yamane Y, Takahara J, Suzuki S, Ota Z, Ofuji T, Takehisa Y.
    Acta Med Okayama; 1979 Aug 21; 33(4):305-14. PubMed ID: 158951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.